Recent Developments: Developed HM15275, a tri-agonist targeting GLP-1, GIP, and glucagon receptors, showing potential for significant weight loss and improved metabolic health
By selecting Klinic, you embrace a supportive, efficient, and patient-centric path to achieving your weight loss goals with tirzepatide
Transplant outcomes depend not only on donor microbiota composition but also on the preexisting microbial structure of the recipient
These studies consistently report favourable renal outcomes (e.g., eGFR, macroalbuminuria, or serum creatinine levels) with GLP-1 receptor agonists
GLP-1 medications work on the hormonal and appetite regulation side and not just your behaviour
It is also indicated for weight management when used alongside a reduced-calorie diet and increased physical activity